概括
组合激素避孕药,包括口服避孕药 (OCP),不需要在手术前停止使用. 不建议停止OCP,以减少术后血栓的风险.
科学领域:
- 麻醉学 麻醉学
- 妇科 妇科 妇科 妇科
- 血管外科 血管外科
背景情况:
- 组合激素避孕 (CHC) 的使用在生育年龄的女性中很普遍.
- 术后管理指南通常建议停止CHC,因为人们担心静脉血栓塞栓症 (VTE).
- 在接受手术的使用CHC的患者中,VTE的实际风险尚未确立.
研究的目的:
- 评估在手术前是否需要停止使用组合激素避孕药.
- 评估在继续与停止CHC的患者中术后静脉血栓栓塞 (VTE) 的风险.
- 为外科手术期间的CHC管理提供基于证据的建议.
主要方法:
- 进行了相关研究的系统审查和元分析.
- 包含的研究是那些在外科手术期间研究CHC使用和VTE风险之间的关联的研究.
- 分析了患者人口统计,外科手术,心脏病类型和静脉瘤事件的数据.
主要成果:
- 分析表明,与停止治疗的患者相比,持续性心脏病患者的静脉瘤风险没有显著增加.
- 在所有组中,手术后血栓的发病率都很低,不管心血管疾病的状况如何.
- 目前的证据不支持常规停止CHC以预防VTE.
结论:
- 在外科手术前期,不建议常规停止组合激素避孕药.
- 停止CHC的决定应根据患者特定的风险因素进行个性化.
- 进一步的研究可能是有必要的,以完善用于CHC用户的术后管理策略.
更多相关视频
相关概念视频
Birth Control Methods
262
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
262
Hormonal Regulation of the Menstrual Cycle
391
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
391
Target Cell Response to Hormones
3.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
Hormonal Control of the Ovarian Cycle
514
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
514
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


